Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.15 USD | +7.51% | +4.30% | -45.69% |
Financials (USD)
Sales 2024 * | 65.3M | Sales 2025 * | 6.25M | Capitalization | 20.99M |
---|---|---|---|---|---|
Net income 2024 * | 26M | Net income 2025 * | -40M | EV / Sales 2024 * | 0.32 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.36 x |
P/E ratio 2024 * |
0.87
x | P/E ratio 2025 * |
-0.55
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.46% |
Latest transcript on MEI Pharma, Inc.
1 day | +7.51% | ||
1 week | +4.30% | ||
Current month | +3.28% | ||
1 month | -4.83% | ||
3 months | -28.25% | ||
6 months | -47.67% | ||
Current year | -45.69% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 3.15 | +7.51% | 13,284 |
24-05-16 | 2.93 | -5.64% | 61,823 |
24-05-15 | 3.105 | -1.74% | 29,032 |
24-05-14 | 3.16 | +1.28% | 14,847 |
24-05-13 | 3.12 | +3.31% | 9,987 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.69% | 20.99M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- MEIP Stock